Cardiac troponin I rise equally occurs after diagnostic coronary angiograms in stable patients  by ban Langenhove, Glenn & Vermeersch, Paul
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tes or hypertension and racewed fewer revascularization procedures (22%) within 30 
days than man (35%, p<O.OOl). Unadjusted l-year swvival was not significantly different 
between men (8%) and women (9%). Advanced age (HRl.06 95%Cl(1.05-1.07)), histo- 
ries of myocardial infarction (MI) (1.7 (1.4-2.0)) 01 heart failure (1.7(1.3-2.1)), diabetes 
(1.3(1 .l-1.6)). hypercholesterolemia (1.3(1 .O-1.5)), ascending quartiles of troponin 
(1.4(1.0-1.9). 1.7(1.3-2.4), 2.2(1.6-3.0)), MI within 30 days (3.4(2.7-4.3)), elevated heart 
rate (1 .OZ(l .Ol-1.02)) and serum creatinine levels (1.4(1.3-1.6)) were associated with a 
higher l-year mortality in both genders, whereas, angioplasty within 30 days was associ- 
ated with lower risk of death (0.5(0.4-0.7)). ST-depresslon (1.3(1.0-l .7) p(interac- 
tion)<0.05) on admission and CRP>lOmg!L (1.3(1.0-l -8) p(interactlon)c0.05) were 
predictors of l-year death in men but not women. Men with Ml on admission were at 
pr* 8hrs 16hrs 24hrs 
Procedure successful (N) 54 
Tropon~n I - rise above 0.1 mgidL (N,(%)) l(2) 6(12) 5(10) 8(16) 
CWCK-MB rise (U/L) 0 0 0 0 
In-hospital events (N) 0 
ECG changes 2 
post procedure (N) 
Adverse events at 15 days (N) 2 
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lower risk of death (0.6(0.4-0.8) p(interaction)=O.OOZ) than women or patients without Ml 
on admission. Conclusions: Although long-term prognosis is comparable between men Conclusion: Surprisingly, significant Troponin I wes were found in up to 16% of patients 
and women with NSTE-ACS. some predictors of death differ, which may have important 
that underwent a diagnostic angiogram for stable coronary artery disease, with no sigmf- 
icant lesions present. These findings may have an impact on conclusions drawn from 
implications for risk management and choice of treatment. previous lntetventional cardiology trials that suggested future events depended upon 
Troponin status following intervention. 
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1003-89 Is Enhanced External Counterpulsation Effective for 
Angina Relief in Diabetic Patients Who Are Not 
Candidates for Transcatheter Intervention? 
Georaiann C. Linnemeier, Elizabeth D. Kennard, Ozlem Soran, Shetyl F. Kelsey, 
University of Pittsburgh, Pittsburgh, PA 
Background: Percutaneous coronary Intervention in the diabetic patient is problematic. 
Enhanced external counterpulsation (EECP) is a noninvasive analogue of the intra-aortic 
balloon pump designed to increase myocardial perfusion pressure and decrease cardiac 
workload. EECP has been demonstrated to be safe and effectwe in treating angina; how- 
ever, the effectiveness of EECP for the treatment of angina in diabetic patients who are 
not considered candidates for transcatheter lntewention is unknown. 
Methods: We analyzed demographic and clinical outcome data from 616 diabetic 
patients (from 32 sites) diagnosed with Canadian Cardiovascular Society (CCS) class Ill 
or IV angina who were not revascularization candidates by referring physician’s assess- 
ment. EECP was given l-2 hours daily with 79% of patients completing a course of treat- 
ment (mean, 37 hours). Patients were followed for six months. 
Results: The mean age was 66 years. and 36% were female. Coronary artery disease 
was of long duration (mean, 11 years), frequently multwessel (81%), and most patients 
had prior percutaneous coronary intervention (74%) or coronary artery bypass surgery 
(72%). Congestive heart failure (44%), and previous myocardial infarction (73%) were 
reported often (mean left ventricular ejection fraction, 45%). Patients were highly symp- 
tomatic, reporting 11.5 episodes of angina/week, requirmg 10.2 sublingual nitroglycerin1 
week. Medical management was considered optimal. Upon completion of treatment, 
88% of patients reported a decrease of >= 1 CCS angina class wth 63% reporting class 
II, I, or no angina. There was a decrease of 8.7 angina1 episodes/week with a concomi- 
tant decrease of 13.2 nitroglycerin/week. At xx-month follow-up, angina reduction was 
maintained in 74% of patients with 74% repomng class II, I, of no angina. 
Conclusion: Despite steady improvement in transcatheter interventional techniques and 
outcomes, there is a growing population of patients who have exhausted the revascular- 
ization armamentarium. Novel treatments such as EECP can offer angina reduction with 
maintenance of benefit for select diabetic patients with advanced coronary artery dis- 
ease. 
Huerin Melina, B. Rolong, R. Henquin, R. Zilberberg, C. Gambarte, 0. Mendoza, M. 
Kriskovich, N. Vainstein, C. Zeballos, L. Guzman, lnstituto Cardiovascular de Buenos 
Aires, Buenos Aires, Argentina 
Increasing levels of homocysteine are strongly associated with the incidence of cardio- 
vascular disease. Recent report appears to indicate a clinical benefit in reducing 
homocysteine levels. Even though it is well established the effectiveness I” reducing 
homocysteine levels with wtamine B complex, the effect of diet is not well documented. 
The aim of the present study was to determine the role of folate-rich diet I” reducing 
homocysteine levels and to compare it effect with the vitamin reduction and with the reg- 
ular secondary prevention recommendations. Sixty patients with prior hlstory of CAD 
were randomly assigned to three different treatments strategies for a three months 
period. The vitamin group (Group V). received vitamin 69: 2.5 mg, B6: 25 mg, and 812: 
0.5 mg; the diet group recewed folate-rich diet (Group D) and a third group received the 
usual secondary preventIon recommendations, and sewed as control (Group C). Base- 
line and 3 months homocysteine levels were measured in all pts. Results: The compli- 
ance with the treatment strategy was 99% for group V and 80% for group D, (p: 0.001). 
Conclusions This prospective randomized study shows that f&ate-rich diet did not 
show any significant benefit in decreasmg homocysteine levels despite a relatively high 
compliance with the diet as compare with the usual secondary prevention recommenda- 
tlons. As expected, vitamin treatment successfully decrease homocysteine levels and 
was well tolerated. 
P from baseline to 3 month: ‘p:O.O2, **p:O.OOOl. 
Homocysteine 
urnoWL 
Baseline 
3 months 
Changes 
Grupo C 
(n:20) 
14+0.8 
12.4+0.7 
-1.7+0.8’ 
Grupo D 
(!l:20) 
14.2+0.8 
12.5+0.7 
-1.7+0.9 
Grupo V 
(n:20) 
16.4+0.98 
10.7+0.5 
-5.7+1.2” 
P Value 
NS 
NS 
0.007 
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Marian 8. Olson, Richard Holubkov, Linda Fried, Virgina Reeser, Sunil Mankad, Carl J. 
Pepine, Richard Kerensky, C. Noel Bairey Merz. Barry L. Sharaf, George Sopko, William 
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1003-90 Cardiac Troponin I Rise Equally Occurs After 
Diagnostic Coronary Angiograms in Stable Patients 
Glenn Van Lanqenhove, Paul Vermeersch, Middelheim Hospital, Antwerp, Belgium 
Background: Troponin I has been suggested as an excellent and early marker of unsta- 
ble coronary artery disease. It has been lknked to future outcome of patients admitted to 
the hospital with unstable coronary syndromes, and in patients that received Interven- 
tional treatment. No literature exists on the occurrence of Troponin I rise following a diag- 
nostic angiogram 
Methods: Patients were only included if they did not have flow-llmiting lesions in their 
coronary artery tree. We prospectively measured Troponin I values before, and 8, 16 and 
24 hours after a diagnostic angiogram and at 14 days after the index procedure. Other 
cardiac enzymes were also assessed. 
Results: No events occurred during hospital stay nor the 14 day follow-up period. A sum- 
mary of the data available IS shown in the table. 
Background: Mild renal insufficiency is associated with an increased risk for cardiovascu- 
lar events in women with coronary artery disease (CAD). However, the relationship 
between mild renal insufficiency and atherosclerotic CAD has not been Investigated. 
Methods: 721 women with chest pal” underwent quantitative coronary angiography, risk 
factor and serum creatinine assessment in the Women’s lschemia Svndrome Evaluation 
(WISE) Study. Estimated creatinine clearance (mllmin) was calculated from serum creat- 
inine usino the Cockroft-Gault eouatlon. Of these. 248 i34%) had an estimated creatinme 
clearance of 50-80 mllmin, defined as mild renal insufficiency; 473 had an estimated 
clearance greater than 80 mllmin. normal renal function. Women with one or more >50% 
dtameter stenosis were classified as having significant CAD. CAD severity score was cal- 
culated using a modified Gensinl index. Interleukin-6 levels were measured in 508 
women. 
Results: As compared to women with normal creatmine clearance, those with mild renal 
Insufficiency were older (64 vs. 54 yrs., p<O.OOl) were more likely have higher systolic 
blood pressure (p=O.Ol), dyslipidemia (p=O.O5) and significant CAD (49% vs 30%, p 
=O.OOl). Modified Gensmi index scores were higher in these women (16 +/-I6 vs. 12 +I- 
12, p< 0.001). Women with mild renal insuffkxncy were 2.3 times more likely to have 
significant CAD (95% Cl 1.6.3.O)(p< 0.001) Mild renal insufficiency was associated with a 
1.6.fold (95% Cl=1 .O-2.6) wreased risk of CAD after adjustment for age. risk factors, 
interleukin 6 levels and use of hormone replacement therapy (pc 0.05). Similar finding 
were noted when using serum creatinine to define renal function. Serum creatinine levels 
of 1.2-1.9, defined as mild renal insufficiency, were associated with a 3.2 fold (95% 
CLl.4.7.2) increase of significant CAD independent of risk factors (pc 0.01) 
